コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 f interferon regulatory factor 1 and the MHC class II transactivator.
2 hal reporter construct and subsequently, the class II transactivator.
3 his in turn was caused by lack of functional class II transactivator.
4 used CRISPR/Cas9 to disrupt the gene for the class II transactivator.
5 nvestigated in cells stably transfected with class II transactivator.
6 is associated with up-regulation of the MHC class II transactivator, a key transcription factor with
7 t ovariectomy up-regulates IFN-gamma-induced class II transactivator, a multitarget immune modulator,
8 prevented transcription of the gene encoding class II transactivator, a transactivator protein requir
9 also induced by HPIV3 in cells defective in class II transactivator, an important intermediate of th
11 nsfection of small interfering RNA targeting class II transactivator attenuates major histocompatibil
12 ecules by small interfering RNA targeting of class II transactivator can reduce the capacity of human
20 The major histocompatibility complex (MHC) class II transactivator (CIITA) acts as a master switch
22 une evasion strategies such as inhibition of class II transactivator (CIITA) and MHC-II expression, t
23 ractions of chromatin-modifying enzymes with class II transactivator (CIITA) and relevant DNA-binding
24 ty complex (MHC)-II and its master regulator class II transactivator (CIITA) are downregulated in CML
25 a signal transduction (Jak/Stat pathway) and class II transactivator (CIITA) are required components
26 igation has defined major histocompatibility class II transactivator (CIITA) as a key factor in media
27 lines were used to demonstrate that the MHC class II transactivator (CIITA) can induce surface expre
29 e-expressed major histocompatibility complex class II transactivator (CIITA) contributes to myeloma-i
30 ells and in a cell line that is defective in class II transactivator (CIITA) demonstrates that NK cel
31 feron-gamma treatment or transduction of the class II transactivator (CIITA) gene induces class II ex
33 t the major histocompatibility complex (MHC) class II transactivator (CIITA) has antiviral activity a
34 anges in cancer immunity mediated by the MHC class II transactivator (CIITA) have not been extensivel
36 scriptional regulation, which is governed by class II transactivator (CIITA) in all cells, microbial
37 P-deficient cells, transfection of exogenous class II transactivator (CIITA) into these RFX-B-deficie
51 complex along with major histocompatibility class II transactivator (CIITA) is induced by interferon
55 The major histocompatibility complex (MHC) class II transactivator (CIITA) is the 'master coactivat
61 The major histocompatibility complex (MHC) class II transactivator (CIITA) is the master regulatory
63 amma-inducible transcription at multiple MHC class II transactivator (CIITA) promoters and suppressed
64 s II MHC genes requires the induction of the class II transactivator (CIITA) protein, a master regula
65 ctivation of class II MHC genes requires the class II transactivator (CIITA) protein, a regulator tha
66 The major histocompatibility complex (MHC) class II transactivator (CIITA) regulates the expression
67 s strictly dependent upon the binding of the class II transactivator (CIITA) to the highly conserved
71 Depending on whether MHC-II genes and the class II transactivator (CIITA) were being expressed, tw
73 on of MHC II antigen A alpha (H2-Aalpha) and Class II transactivator (Ciita), a master regulator of M
75 have now transduced tumor cells with the MHC class II transactivator (CIITA), a regulatory gene that
77 tion analysis demonstrated that induction of class II transactivator (CIITA), and consequently, HLA-D
79 ter regulator of MHC class II transcription, class II transactivator (CIITA), identified HLA-DOA and
80 re, inhibition of promoter activities of MHC class II transactivator (CIITA), IFN-gamma-activated sit
81 ated inhibition of MNV replication in vitro, class II transactivator (CIITA), interferon regulatory f
82 mary and immortalized astrocytes up-regulate class II transactivator (CIITA), invariant chain (Ii) (p
85 anism involved interactions between CTCF and class II transactivator (CIITA), the master regulator of
86 uires recruitment of a master regulator, the class II transactivator (CIITA), to the MHC class II pro
87 orrelating to a decrease in the mRNA for the class II transactivator (CIITA), whereas CIITA expressio
88 nodeficiency have mutations in a gene termed class II transactivator (CIITA), which coordinately cont
89 non-DNA-binding master regulator of MHC-II, class II transactivator (CIITA), which is crucial for en
90 t the major histocompatibility complex (MHC) class II transactivator (CIITA), which is required for e
91 of several immune function genes, including class II transactivator (CIITA), which regulates class I
93 in line with the role of CREBBP in promoting class II transactivator (CIITA)-dependent transcriptiona
109 s due to a decrease in the expression of the class II transactivator (CIITA).IMPORTANCE Human cytomeg
110 of the key mechanisms includes repression of class-II transactivator (CIITA) and MHC-II expression in
111 ages is mediated via epigenetic silencing of class II transactivator, CIITA, the master regulator of
112 y the major histocompatibility complex (MHC) class II transactivator, CIITA, which binds to myogenin
115 3 that inhibits promoter function of the HLA class II transactivator, decreasing expression of genes
117 tion and targeted IFN response factor 1- and class II transactivator-dependent and independent promot
118 pathways including Stat-3, beta-catenin, and class II transactivator-dependent antigen presentation.
125 was accompanied by activation of a repressed class II transactivator gene in a plasma cell tumor but,
126 t from a pig transgenic for a mutant (human) class II transactivator gene, resulting in down-regulati
127 in reaction analysis for gene transcripts of class II transactivator, HLA-DRagr;, and HLA-DRbeta1 sho
128 nducible genes-MHC class II gene E beta; MHC class II transactivator; IFN regulatory factor-1; and Mg
132 demonstrate that NOD mice lacking the CIITA (class II transactivator) molecule, and hence deficient i
133 tion of the IFN gamma-responsive chromosomal class II transactivator promoter revealed that MCMV infe
135 by either IFN-alpha/beta (Mx1) or IFN-gamma (class II transactivator protein [CIITA] and inducible ni
136 gen-activated protein kinase, NF-kappaB, the class II transactivator, RFX5, and the IFN regulatory fa
137 ion arises from biallelic gene disruption in class II transactivator that leaves other essential prop
139 ested that NLRC5 acts in a manner similar to class II transactivator to drive MHC expression and reve
141 e selective: while transcription of CD64 and class II transactivator were decreased, certain other IF
143 d proteins form a platform that attracts the class II transactivator, which initiates and elongates M